Profiel
Kristin Bedard served as the Chief Scientific Officer-Immuno oncology at Kineta, Inc. from 2016 to 2020.
She then worked as the Vice President-Immunobiology at Sutro Biopharma, Inc. from 2020 to 2023.
Dr. Bedard completed her undergraduate degree at The Pennsylvania State University in 1998.
She later earned her doctorate degree from the University of California, Irvine in 2005.
Eerdere bekende functies van Kristin Bedard
Bedrijven | Functie | Einde |
---|---|---|
SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01-06-2023 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01-02-2020 |
Opleiding van Kristin Bedard
The Pennsylvania State University | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SUTRO BIOPHARMA, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |